Omkar Pharmachem has informed that the meeting of Board of Directors of the company will be held on Thursday, 14th December, 2017 at 1.00 p.m. at the registered office of the Company, to consider, approve and take on record the Unaudited financial results along with Limited Review Report for the quarter and half year ended on 30th September, 2017, required under Regulation 33 of the SEBI (Listing Obligation And Disclosure Requirement) Regulation 2015. As per SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the securities of the Company, shall remain closed for all Directors / KMPs / Designated Employees / Connected Persons from December 06, 2017 till December 16, 2017 i.e. 48 hours after communication of aforesaid Un-Audited Financial Results to the Stock Exchanges.
The above information is a part of company’s filings submitted to BSE.